MyChesCo on MSN7d
Century Therapeutics Expands Clinical Focus and Reports Steady Financials for Q3 2024
Century Therapeutics, Inc. (NASDAQ: IPSC) has announced its financial results and business updates for the third quarter of ...
Century Therapeutics Announces Financial Results and Updates Slide Presentation
Century Therapeutics, Inc. (NASDAQ:IPSC) recently disclosed its financial results for the quarter ending September 30, 2024, through a press release issued on November 5, 2024. The company’s press ...
Century Therapeutics price target lowered to $11 from $17 at Chardan
Chardan analyst Geulah Livshits lowered the firm’s price target on Century Therapeutics (IPSC) to $11 from $17 and keeps a Buy rating on ...